Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-23-088350

Options or other derivatives

  • Chief Operating Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Frankenfield Christopher James · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X05/tm2323038-2_4seq1.xml…